Nektar Therapeutics (NKTR) Tops Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $70.68 -0.13%
Revenue Growth %: -7.1%
Financial Fact:
General and administrative: 10.25M
Today's EPS Names:
QCOM, QCOM, TIPT, More
Revenue Growth %: -7.1%
Financial Fact:
General and administrative: 10.25M
Today's EPS Names:
QCOM, QCOM, TIPT, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q3 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $24.1 million versus the consensus estimate of $21.26 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark Electronics (BHE) Tops Q2 EPS by 16c; offers guidance
- Vista Gold Corp (VGZ) Reports Q2 Loss of $0.02
- Q2 Holdings (QTWO) Tops Q2 EPS by 2c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
